Brief: Interpace Biosciences Reports Q2 2020 Results
Oct 20 (Reuters) - Interpace Biosciences Inc IDXG.O :
* INTERPACE BIOSCIENCES ANNOUNCES SECOND QUARTER 2020
FINANCIAL
AND BUSINESS RESULTS
* Q2 REVENUE $5.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$5.9
MILLION
Source text for Eikon: ID:nGNX7Jjd1Z
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))